Idun Bakke B.
- Country
- Norway
- Department
- Department of Oncology
Research Overview
Data & Insights
Has run more than one trial at 7 of 31 partner sites.
Specializations
Lymphoma Research
This investigator specializes in treating lymphoproliferative disorders, with particular emphasis on follicular lymphoma and mantle cell lymphoma. Their research encompasses innovative therapeutic approaches for both newly diagnosed and relapsed patients.
- Follicular Lymphoma Management
- Mantle Cell Lymphoma Treatment
- Novel Therapeutic Strategies
Their work includes evaluation of targeted therapies and immunotherapy combinations in lymphoid malignancies.
Targeted Therapies
The investigator focuses on developing treatment strategies using targeted therapeutic agents, including BTK inhibitors and monoclonal antibodies. Their research particularly addresses the needs of specific patient populations, including elderly patients and those with early relapse.
- Immunotherapy Applications
- Combination Treatment Approaches
- Second-line Treatment Strategies
Their expertise extends to investigating novel drug combinations and treatment sequences in lymphoma therapy.
Clinical Outcomes
The investigator's research emphasizes progression-free survival and treatment efficacy in hematologic malignancies. They conduct studies comparing novel treatment approaches with established therapeutic standards.
- Treatment Response Assessment
- Early Relapse Management
- Therapeutic Efficacy Evaluation
Their work includes multicenter clinical trials and collaborative research across Nordic countries.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.